TEST POST
test content
Similar Posts
Diphenidine and Schedule I: What DEA’s Proposed Rule Means Right Now
PRORULE – 2026-05-26
CMS Telehealth Reimbursement Changes for 2026: What Every Provider Needs to Know
Yes, but the headline change isn’t really a CMS decision at all. It’s that Congress let Medicare telehealth coverage lapse twice in the past nine months before finally locking in a genuine multi-year extension. If you missed either lapse, here’s what actually happened and where things stand now. What Actually Happened to Medicare Telehealth Coverage…
Compounding Pharmacy and Telehealth: What Providers Need to Know About the DEA Rules
DEA’s compounding rules aren’t really about whether a pharmacy can compound a controlled substance. They’re about who’s doing it, how much, and whether the volume crosses from individualized dispensing into something that looks more like unregistered manufacturing. What Does DEA Actually Allow a Pharmacy to Compound? Under DEA’s compounding policy, a registered pharmacy can compound…
State Telehealth Prescribing Laws: What Federal Rules Don’t Cover
Federal DEA and HHS telemedicine rules set a floor, not a ceiling. Most of what actually trips providers up isn’t federal at all, it’s the state-level layer sitting on top that federal rules were never designed to touch. What Do Federal Rules Actually Cover? The Ryan Haight Act and DEA’s telemedicine exceptions, including the current…
CMS 2026 Medicare Fee Schedule: Key Telehealth Changes for Providers
Yes, CMS made real changes to telehealth in this year’s fee schedule, a streamlined process for adding services, new codes, a higher originating site fee, and a permanent supervision rule. It also turned down a few things telehealth advocates were pushing for, which matters just as much. What’s the Biggest Procedural Change to the Telehealth…